[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.74.94. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
February 12, 2003

Losartan vs Atenolol in Prevention of Stroke and Cardiovascular Disease

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;289(6):700-701. doi:10.1001/jama.289.6.700-a

In Reply: In response to Dr Fournier and colleagues and Dr Messerli and colleagues, we too are uncertain why losartan prevented stroke to such a greater extent than atenolol with the same level of blood pressure reduction, yet why the 2 regimens were equal in preventing myocardial infarction. Although our study did not address mechanisms, there are preclinical data in models such as the stroke-prone spontaneously hypertensive rat that show a benefit of angiotensin AT1-receptor blockade with losartan on cerebrovascular structure and prevention of cerebral lesions in the absence of an effect on blood pressure.1 In this context, AT2-receptor stimulation in addition to AT1-receptor blockade for greater selective cerebral protection seems intriguing.2 In addition, pending results of mechanistic substudies of our study may potentially shed light on the cerebrovascular protective properties of losartan.3

First Page Preview View Large
First page PDF preview
First page PDF preview
×